The Option Value of Innovative Treatments for Non–Small Cell Lung Cancer and Renal Cell CarcinomaByJulia Thornton Snider, PhD,Katharine Batt, MD, MSc,Yanyu Wu, PhD,Mahlet Gizaw Tebeka, MS,Seth Seabury, PhDOctober 25th 2017Option value is the benefit a therapy provides patients by enabling them to survive to the next innovation.